Author: Kim Tae-Geum Yu Jie Hough John Henderson David Langridge William H. R.
Publisher: Humana Press, Inc
ISSN: 1073-6085
Source: Molecular Biotechnology, Vol.30, Iss.3, 2005-07, pp. : 221-230
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
To assess the immunomodulatory activity of the HIV Tat transduction peptide for enhancement of suppression of Type 1 autoimmune diabetes, the 11 amino acid HIV-1 Tat transduction peptide was genetically linked to the major islet autoantigens proinsulin (INS) and glutamic acid decarboxylase (GAD). The Tat-autoantigen fusion proteins were synthesized in Escherichia coli and characterized by acrylamide gel separation and immunoblot analysis. Histological examination of pancreatic islets isolated from juvenile NOD mice inoculated orally with the Tat-autoantigen conjugates revealed a significant reduction in islet inflammation (insulitis) in comparison with islets from unimmunized mice. Increased serum IgG1 antibody isotype titers detected in Tat-autoantigen inoculated mice suggest that the transduction peptide-autoantigen fusion proteins stimulate Th2 lymphocyte mediated bystander suppression. The reduction of islet insulitis observed in Tat-autoantigen inoculated mice suggests that the adjuvant effect of the Tat transduction peptide resides in Tat enhanced delivery of linked autoantigens through enterocytes to lymphocytes in the gut-associated lymphoid tissues.
Related content
Production of HIV-1 p24 Protein in Transgenic Tobacco Plants
By Zhang G.G. Rodrigues L. Rovinski B. White K.A.
Molecular Biotechnology, Vol. 20, Iss. 2, 2002-02 ,pp. :
By Ishaq Musarat Hu Jiajie Wu Xiaoyun Fu Qiong Yang Yalin Liu Qingzhen Guo Deyin
Molecular Biotechnology, Vol. 39, Iss. 3, 2008-07 ,pp. :